Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Clinical
Title:
Vivo Development Ltd
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Shanghai
China
Contact Info:
n/a
Webpage:
www.vivodevelopment.com
HQ
Contact Info:
Suite 109, 518 Bibo Road, Zhang Jiang High Tech Park, Pudong New Area, Shanghai 201203, China
Tel: +86 21 5027 5346; 50275347; 50275348
Fax: +86 21 5027 5349
Email: Contact@vivodevelopment.com
Additional
Contact Info:
n/a
Description:
Vivo Development Ltd. is a clinical CRO, based in Shanghai, China. Its management team is consisted of both highly experienced returnees from North America and homegrown pharmaceutical/medical scientists from top tier multi-national pharmaceutical companies.
It is familiar with the Chinese regulatory system and connected to most of the top-rated urban hospitals and clinical trial centers that are GCP certified by the SFDA. Moreover, it has experience with ICH and FDA requirements on GCP from working at multi-national drug companies. This distinctive combination well positions it to provide clinical trial services to domestic, as well as international clients. In addition, Vivo has access to two premier clinical trial centers in Hong Kong, thereby offering its clients with US FDA inspected facilities.
As a separate business model, Vivo provides serves to license pharmaceutical products in and out of China, a two-way technology transfer process that brings the Chinese academic research and a growing pharmaceutical market closer to the rest of IP intensive pharmaceutical world.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit